Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Celution Prepared Adipose Derived Regenerative Cells in the Treatment of Osteoarthritis of the Knee: A Double-blind, Placebo Controlled, Multi-center Safety and Feasibility Study

NCT02326961 is registered in ClinicalTrials.gov with Cytori Therapeutics as lead sponsor.

NCT NCT02326961
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02326961 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Celution Prepared Adipose Derived Regenerative Cells in the Treatment of Osteoarthritis of the Knee: A Double-blind, Placebo Controlled, Multi-center Safety and Feasibility Study
Lead sponsor
Cytori Therapeutics
Phase
Phase 2
Overall status
Completed
Start date
January 31, 2015
Completion date
October 31, 2016
Enrollment
94 (actual)
Sites
11

Conditions

As the registry lists them; a condition with its own page is linked.

osteoarthritis, knee